• About Us
    • Our Team
    • Our Work
    • In The News
  • Resources
    • Curated Research Library
    • Articles
    • Legal Beagle Archive
    • The Education Program
    • VCS Vet Research Program
  • Directory of Practitioners
  • Get Involved
    • Become A Sponsor
    • Join Email List
  • Contact
  • SHOP NOW
    • VCS APPAREL
    • PET & PARENT JEWELRY
  • DONATE
  • Members Dashboard
Veterinary Cannabis SocietyVeterinary Cannabis Society
  • About Us
    • Our Team
    • Our Work
    • In The News
  • Resources
    • Curated Research Library
    • Articles
    • Legal Beagle Archive
    • The Education Program
    • VCS Vet Research Program
  • Directory of Practitioners
  • Get Involved
    • Become A Sponsor
    • Join Email List
  • Contact
  • SHOP NOW
    • VCS APPAREL
    • PET & PARENT JEWELRY
  • DONATE
  • Members Dashboard

rat

α2-Adrenoceptor agonist induces peripheral antinociception via the endocannabinoid system

Apr 21, 2021

Abstract Background Xylazine is an α2 adrenoceptor agonist that is extensively used in veterinary medicine and animal experimentation procedures to produce...

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Apr 21, 2021

Abstract Asthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce...

Long-Term Aberrations To Cerebellar Endocannabinoids Induced By Early-Life Stress

Apr 21, 2021

Abstract Emerging evidence points to the role of the endocannabinoid system in long-term stress-induced neural remodeling with studies on stress-induced...

The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats

Apr 21, 2021

Abstract The changes in sympathetic innervations in lymphoid organs could be a key factor in immune dysregulation. The endocannabinoid system...

Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects

Apr 20, 2021

Abstract There is now a large body of data that indicates that the CB2 cannabinoid receptor type 2 (CB2) is linked...

Search Our Website

Recent In The News

  • CBD Oracle Interviews VCS Board and Sponsors
  • New York Times: Mammals with the Munchies
  • Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
  • BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
  • Cannabis in Veterinary Medicine | Continual Education | VIN
  • Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
  • A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
  • Earth Buddy, Pet Calming Study – Press Release
  • CALIFORNIA CANNABIS UPDATES – April 2022
  • Cannabis in Veterinary Practice Multi-Expert Webinar

Our Mission is to create lasting solutions that ensure the safe use of cannabis in pets through education, advocacy, and promoting product standards.

Our Vision is an educated and empowered global veterinary medical cannabis community.

  • About Us
  • Our Work
  • Get Involved
  • Contact Us
  • Donate

Email:
Click here to email us

Florida Mailing Address
7901 4th St. North, Suite 4404
St. Petersburg, FL 33702

Veterinary Cannabis Society is a nonprofit, 501(c)(3) organization in the United States. Tax ID #85-0986090

Veterinary Cannabis Society does not endorse any specific products.

© 2024 · Veterinary Cannabis Society

  • Terms of Use
  • Privacy Policy
  • State Notices
  • Contact